{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:24:55Z","timestamp":1791195895289,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005756","name":"Shahrekord University of Medical Sciences","doi-asserted-by":"publisher","award":["SKUMS-5206"],"award-info":[{"award-number":["SKUMS-5206"]}],"id":[{"id":"10.13039\/501100005756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005756","name":"Shahrekord University of Medical Sciences","doi-asserted-by":"publisher","award":["SKUMS-5204"],"award-info":[{"award-number":["SKUMS-5204"]}],"id":[{"id":"10.13039\/501100005756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-28479-4","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T19:34:58Z","timestamp":1763926498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigating of harmane, harmine, and norharman as inhibitors of MDR1 and MRP1 to overcome chemotherapy resistance in cancer cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Neda","family":"Abdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezou","family":"Banitalebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razieh","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorur","family":"Zahedian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Abbas","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Elahian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,23]]},"reference":[{"key":"28479_CR1","unstructured":"R\u00e4tsch, C. The Encyclopedia of Psychoactive Plants: Ethnopharmacology and its Applications (Simon and Schuster, 2005)."},{"key":"28479_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/B978-0-444-63430-6.00004-7","volume":"43","author":"CDS Passos","year":"2014","unstructured":"Passos, C. D. S. et al. Alkaloids as inhibitors of monoamine oxidases and their role in the central nervous system. Stud. Nat. Prod. Chem. 43, 123\u2013144 (2014).","journal-title":"Stud. Nat. Prod. Chem."},{"issue":"5","key":"28479_CR3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/ijc.20703","volume":"114","author":"Q Chen","year":"2005","unstructured":"Chen, Q. et al. Antitumor and neurotoxic effects of novel Harmine derivatives and structure-activity relationship analysis. Int. J. Cancer. 114 (5), 675\u2013682 (2005).","journal-title":"Int. J. Cancer"},{"issue":"3","key":"28479_CR4","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.fct.2009.12.019","volume":"48","author":"T Herraiz","year":"2010","unstructured":"Herraiz, T. et al. \u03b2-Carboline alkaloids in peganum Harmala and Inhibition of human monoamine oxidase (MAO). Food Chem. Toxicol. 48 (3), 839\u2013845 (2010).","journal-title":"Food Chem. Toxicol."},{"issue":"6","key":"28479_CR5","first-page":"1995","volume":"54","author":"Y Ding","year":"2019","unstructured":"Ding, Y. et al. Harmine induces anticancer activity in breast cancer cells via targeting TAZ. Int. J. Oncol. 54 (6), 1995\u20132004 (2019).","journal-title":"Int. J. Oncol."},{"issue":"3","key":"28479_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0031-9422(00)82825-3","volume":"1","author":"E Poindexter Jr","year":"1962","unstructured":"Poindexter, E. Jr & Carpenter, R. The isolation of Harmane and Norharmane from tobacco and cigarette smoke. Phytochemistry 1 (3), 215\u2013221 (1962).","journal-title":"Phytochemistry"},{"issue":"4","key":"28479_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11051-023-05712-7","volume":"25","author":"S Shahbazi","year":"2023","unstructured":"Shahbazi, S. et al. Eugenol-loaded mesoporous silica nanoparticles enhance the sensitivity of cisplatin against AGS human gastric adenocarcinoma cell line. J. Nanopart. Res. 25 (4), 57 (2023).","journal-title":"J. Nanopart. Res."},{"issue":"6","key":"28479_CR8","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.7314\/APJCP.2012.13.6.2979","volume":"13","author":"F Kalalinia","year":"2012","unstructured":"Kalalinia, F. et al. Phorbol ester TPA modulates chemoresistance in the drug sensitive breast cancer cell line MCF-7 by inducing expression of drug efflux transporter ABCG2. Asian Pac. J. Cancer Prev. 13 (6), 2979\u20132984 (2012).","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"11","key":"28479_CR9","doi-asserted-by":"publisher","first-page":"20769","DOI":"10.1002\/jcp.28683","volume":"234","author":"N Gholamian Dehkordi","year":"2019","unstructured":"Gholamian Dehkordi, N. et al. Intelligent TAT-coupled anti\u2010HER2 immunoliposomes knock downed MDR1 to produce chemosensitize phenotype of multidrug resistant carcinoma. J. Cell. Physiol. 234 (11), 20769\u201320778 (2019).","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"28479_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10787-020-00765-9","volume":"29","author":"N Gholamian Dehkordi","year":"2021","unstructured":"Gholamian Dehkordi, N., Mirzaei, S. A. & Elahian, F. Pharmacodynamic mechanisms of anti-inflammatory drugs on the chemosensitization of multidrug-resistant cancers and the pharmacogenetics effectiveness. Inflammopharmacology 29 (1), 49\u201374 (2021).","journal-title":"Inflammopharmacology"},{"issue":"1","key":"28479_CR11","first-page":"e70098","volume":"8","author":"R Heidari","year":"2025","unstructured":"Heidari, R. et al. The miRNA-mRNA regulatory network in human hepatocellular carcinoma by transcriptomic analysis from GEO. Cancer Rep. 8 (1), e70098 (2025).","journal-title":"Cancer Rep."},{"key":"28479_CR12","doi-asserted-by":"crossref","unstructured":"Taheri, F. et al. Mechanism and function of miR-140 in human cancers: A review and in silico study. 241, 154265. (2023).","DOI":"10.1016\/j.prp.2022.154265"},{"issue":"3","key":"28479_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nrm2646","volume":"10","author":"DC Rees","year":"2009","unstructured":"Rees, D. C., Johnson, E. & Lewinson, O. ABC transporters: the power to change. Nat. Rev. Mol. Cell Biol. 10 (3), 218\u2013227 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"28479_CR14","doi-asserted-by":"crossref","unstructured":"El-Awady, R. et al. The role of eukaryotic and prokaryotic ABC transporter family in failure of chemotherapy. Front. Pharmacol. 7. (2017).","DOI":"10.3389\/fphar.2016.00535"},{"key":"28479_CR15","doi-asserted-by":"crossref","unstructured":"Finch, A. & Pillans, P. P-glycoprotein and its role in drug-drug interactions. Australian Prescriber  37 (4). (2014).","DOI":"10.18773\/austprescr.2014.050"},{"issue":"4","key":"28479_CR16","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1109\/TNB.2023.3242912","volume":"22","author":"ZR Harandi","year":"2023","unstructured":"Harandi, Z. R., Heidari, R. & Reiisi, S. Co-delivery of Silymarin and Metformin dual-loaded in mesoporous silica nanoparticles synergistically sensitizes breast cancer cell line to Mitoxantrone chemotherapy. IEEE Trans. Nanobiosci. 22 (4), 872\u2013880 (2023).","journal-title":"IEEE Trans. Nanobiosci."},{"key":"28479_CR17","doi-asserted-by":"crossref","unstructured":"Zheng, Y., Ma, L. & Sun, Q. Clinically-relevant ABC transporter for anti-cancer drug resistance. Front. Pharmacol. 12. (2021).","DOI":"10.3389\/fphar.2021.648407"},{"key":"28479_CR18","doi-asserted-by":"publisher","first-page":"103091","DOI":"10.1016\/j.bioorg.2019.103091","volume":"91","author":"JL Rodr\u00edguez-Ch\u00e1vez","year":"2019","unstructured":"Rodr\u00edguez-Ch\u00e1vez, J. L. et al. Chemo-sensitizing activity of natural cadinanes from heterotheca Inuloides in human uterine sarcoma cells and their in Silico interaction with ABC transporters. Bioorg. Chem. 91, 103091 (2019).","journal-title":"Bioorg. Chem."},{"issue":"3","key":"28479_CR19","doi-asserted-by":"publisher","first-page":"1600060","DOI":"10.1002\/minf.201600060","volume":"36","author":"S Sepehri","year":"2017","unstructured":"Sepehri, S., Saghaie, L. & Fassihi, A. Anti-HIV\u20101 activity prediction of novel gp41 inhibitors using structure\u2010based virtual screening and molecular dynamics simulation. Mol. Inf. 36 (3), 1600060 (2017).","journal-title":"Mol. Inf."},{"issue":"1","key":"28479_CR20","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1038\/s41598-018-21710-5","volume":"8","author":"SA Mirzaei","year":"2018","unstructured":"Mirzaei, S. A. et al. Broad blocking of MDR efflux pumps by acetylshikonin and acetoxyisovalerylshikonin to generate hypersensitive phenotype of malignant carcinoma cells. Sci. Rep. 8 (1), 3446 (2018).","journal-title":"Sci. Rep."},{"key":"28479_CR21","first-page":"115989","volume":"441","author":"M Safaei","year":"2022","unstructured":"Safaei, M. et al. Enzyme-sensitive nanoparticles, smart TAT and cetuximab conjugated immunoliposomes to overcome multidrug resistance. Breast Cancer Cells. 441, 115989 (2022).","journal-title":"Breast Cancer Cells"},{"key":"28479_CR22","doi-asserted-by":"crossref","unstructured":"Elahian, F. et al. Unlike morphine, long-term exposure to analgesic mitragynine, 7-hydroxymitragynine, paynantheine, and speciociliatine alkaloids does not contribute to antinociceptive tolerance of \u00b5-opioid receptors. (2020).","DOI":"10.21203\/rs.3.rs-39727\/v1"},{"key":"28479_CR23","doi-asserted-by":"crossref","unstructured":"Hemming, S., Cakouros, D. & Gronthos, S. J. S. C. Detachment of mesenchymal stem cells with trypsin\/EDTA has no effect on apoptosis detection. 32 (7), 1991\u20131992. (2014).","DOI":"10.1002\/stem.1710"},{"key":"28479_CR24","doi-asserted-by":"crossref","unstructured":"Donnenberg, V. S. et al. Flow cytometric detection of most proteins in the cell surface proteome is unaffected by trypsin treatment. 93 (8), 803\u2013810. (2018).","DOI":"10.1002\/cyto.a.23525"},{"key":"28479_CR25","doi-asserted-by":"crossref","unstructured":"Wang, E. et al. In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein. 28 (5), 522\u2013528. (2000).","DOI":"10.1016\/S0090-9556(24)15095-7"},{"key":"28479_CR26","doi-asserted-by":"crossref","unstructured":"Mirzaei, S. A. et al. ABC-transporter blockage mediated by xanthotoxin and bergapten is the major pathway for chemosensitization of multidrug-resistant cancer cells. 337, 22\u201329. (2017).","DOI":"10.1016\/j.taap.2017.10.018"},{"issue":"8","key":"28479_CR27","first-page":"1419","volume":"42","author":"N Soheili","year":"2020","unstructured":"Soheili, N. et al. Design and evaluation of biological gate circuits and their therapeutic applications. model. Multidrug Resistant Cancers. 42 (8), 1419\u20131429 (2020).","journal-title":"model. Multidrug Resistant Cancers"},{"key":"28479_CR28","doi-asserted-by":"crossref","unstructured":"Karimzadeh, F. et al. Design, synthesis, and evaluation of cell-penetrating anticancer peptides to enhance the antitumor activity of liposomal daunorubicin: a molecular dynamics and experimental study. 107115. (2025).","DOI":"10.1016\/j.jddst.2025.107115"},{"issue":"5","key":"28479_CR29","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00280-016-3044-4","volume":"78","author":"NR Srinivas","year":"2016","unstructured":"Srinivas, N. R. Understanding the role of tariquidar, a potent Pgp inhibitor, in combination trials with cytotoxic drugs: what is missing? Cancer Chemother. Pharmacol. 78 (5), 1097\u20131098 (2016).","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"28479_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbrc.2018.02.205","volume":"498","author":"X Geng","year":"2018","unstructured":"Geng, X. et al. Harmines inhibit cancer cell growth through coordinated activation of apoptosis and Inhibition of autophagy. Biochem. Biophys. Res. Commun. 498 (1), 99\u2013104 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"28479_CR31","first-page":"135","volume":"44","author":"L Zheng","year":"2006","unstructured":"Zheng, L. et al. Identification of Norharman as the cytotoxic compound produced by the sponge (Hymeniacidon perleve)-associated marine bacterium pseudoalteromonas piscicida and its apoptotic effect on cancer cells. Biotechnol. Appl. Chem. 44 (3), 135\u2013142 (2006).","journal-title":"Biotechnol. Appl. Chem."},{"key":"28479_CR32","doi-asserted-by":"crossref","unstructured":"Wang, Y. et al. Design, synthesis, and biological evaluation of \u03b2-carboline derivatives as ABCB1 inhibitors for reversing multidrug resistance. 288, 117390. (2025).","DOI":"10.1016\/j.ejmech.2025.117390"},{"key":"28479_CR33","doi-asserted-by":"crossref","unstructured":"Zhang, H. et al. The BTK inhibitor ibrutinib (PCI-32765) overcomes Paclitaxel resistance in ABCB1-and ABCC10-overexpressing cells and tumors. 16 (6), 1021\u20131030. (2017).","DOI":"10.1158\/1535-7163.MCT-16-0511"},{"key":"28479_CR34","doi-asserted-by":"crossref","unstructured":"Dimitrijevic, D. et al. Toward realistic dosimetry in vitro: determining effective concentrations of test substances in cell culture and their prediction by an in silico mass balance model. 35 (11), 1962\u20131973. (2022).","DOI":"10.1021\/acs.chemrestox.2c00128"},{"key":"28479_CR35","doi-asserted-by":"crossref","unstructured":"Jansson-L\u00f6fmark, R. et al. Does in vitro potency predict clinically efficacious concentrations? 108 (2), 298\u2013305. (2020).","DOI":"10.1002\/cpt.1846"},{"issue":"4","key":"28479_CR36","first-page":"1690","volume":"5","author":"M Srinivasan","year":"2015","unstructured":"Srinivasan, M., Rajabi, M. & Mousa, S. A. J. N. Multifunctional Nanomaterials their Appl. Drug Delivery Cancer Therapy 5(4): 1690\u20131703. (2015).","journal-title":"Multifunctional Nanomaterials their Appl. Drug Delivery Cancer Therapy"},{"key":"28479_CR37","unstructured":"Mori, R. et al. P-glycoprotein plays an important role in the cross-resistance to taxanes in 5FU-resistant gastric cancer cells. 4,  12330\u201312130. (2015)."},{"key":"28479_CR38","doi-asserted-by":"crossref","unstructured":"Huang, B. Y. et al. Uncaria alkaloids reverse ABCB1-mediated cancer multidrug resistance. 51 (1), 257\u2013268. (2017).","DOI":"10.3892\/ijo.2017.4005"},{"key":"28479_CR39","doi-asserted-by":"crossref","unstructured":"Chen, X. Y. et al. Overexpression of ABCC1 confers drug resistance to betulin. 11, 640656. (2021).","DOI":"10.3389\/fonc.2021.640656"},{"key":"28479_CR40","doi-asserted-by":"crossref","unstructured":"Chen, G. et al. A 20 (S)-protopanoxadiol derivative overcomes multi-drug resistance by antagonizing ATP-binding cassette subfamily B member 1 transporter function. 7 (8), 9388. (2016).","DOI":"10.18632\/oncotarget.7011"},{"key":"28479_CR41","doi-asserted-by":"crossref","unstructured":"Zhang, H. et al. In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1. 171 (24), 5845\u20135857. (2014).","DOI":"10.1111\/bph.12889"},{"key":"28479_CR42","doi-asserted-by":"crossref","unstructured":"Yang, Y. et al. Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor. 40 (7), 285\u2013300. (2020).","DOI":"10.1002\/cac2.12040"},{"key":"28479_CR43","doi-asserted-by":"crossref","unstructured":"Mlejnek, P. et al. Can image analysis provide evidence that lysosomal sequestration mediates daunorubicin resistance? 327,  109138. (2020).","DOI":"10.1016\/j.cbi.2020.109138"},{"key":"28479_CR44","unstructured":"Hindenburg, A. A. et al. Intracellular distribution and pharmacokinetics of Daunorubicin in anthracycline-sensitive and-resistant HL-60 cells. 49 (16), 4607\u20134614. (1989)."},{"key":"28479_CR45","doi-asserted-by":"crossref","unstructured":"McGown, A. T. et al. Comparative studies of the uptake of daunorubicin in sensitive and resistant P388 cell lines by flow cytometry and biochemical extraction procedures. 11 (2), 113\u2013116. (1983).","DOI":"10.1007\/BF00254258"},{"key":"28479_CR46","doi-asserted-by":"crossref","unstructured":"Cui, H. et al. ABC transporter inhibitors in reversing multidrug resistance to chemotherapy. 16 (12), 1356\u20131371. (2015).","DOI":"10.2174\/1389450116666150330113506"},{"key":"28479_CR47","doi-asserted-by":"crossref","unstructured":"Stefan, K. & Schmitt, S. M. and M.J.J.o.m.c. Wiese, 9-Deazapurines as broad-spectrum inhibitors of the ABC transport proteins P-glycoprotein, multidrug resistance-associated protein 1, and breast cancer resistance protein. 60  (21), 8758\u20138780. (2017).","DOI":"10.1021\/acs.jmedchem.7b00788"},{"key":"28479_CR48","doi-asserted-by":"crossref","unstructured":"Sorf, A. et al. Targeting pharmacokinetic drug resistance in acute myeloid leukemia cells with CDK4\/6 inhibitors. 12 (6), 1596. (2020).","DOI":"10.3390\/cancers12061596"},{"key":"28479_CR49","doi-asserted-by":"crossref","unstructured":"Mirzaei, S. A. et al. Broad blocking of MDR efflux pumps by acetylshikonin and acetoxyisovalerylshikonin to generate hypersensitive phenotype of malignant carcinoma cells. 8 (1), 3446. (2018).","DOI":"10.1038\/s41598-018-21710-5"},{"key":"28479_CR50","doi-asserted-by":"crossref","unstructured":"Eid, S. Y. et al. Influence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and colon cancer cells. 21 (1), 47\u201361. (2013).","DOI":"10.1016\/j.phymed.2013.07.019"},{"key":"28479_CR51","doi-asserted-by":"crossref","unstructured":"Ma, Y. & Wink, M. The beta-carboline alkaloid Harmine inhibits BCRP and can reverse resistance to the anticancer drugs Mitoxantrone and camptothecin in breast cancer cells. Phytother.  Res. Int. J.  Devoted Pharmacol. Toxicol. Eval.  Nat. Prod.  Derivat. 24 (1), 146\u2013149. (2010).","DOI":"10.1002\/ptr.2860"},{"key":"28479_CR52","doi-asserted-by":"crossref","unstructured":"Klimoszek, D. et al. Study of the lipophilicity and ADMET parameters of new anticancer diquinothiazines with pharmacophore substituents. 17 (6),  725. (2024).","DOI":"10.3390\/ph17060725"},{"key":"28479_CR53","doi-asserted-by":"crossref","unstructured":"Hu, M. et al. A novel lipophilic Amiloride derivative efficiently kills chemoresistant breast cancer cells. 14 (1), 20263. (2024).","DOI":"10.1038\/s41598-024-71181-0"},{"issue":"13","key":"28479_CR54","doi-asserted-by":"publisher","first-page":"6121","DOI":"10.1021\/acs.jmedchem.6b00035","volume":"59","author":"A Spindler","year":"2016","unstructured":"Spindler, A., Stefan, K. & Wiese, M. Synthesis and investigation of tetrahydro-\u03b2-carboline derivatives as inhibitors of the breast cancer resistance protein (ABCG2). J. Med. Chem. 59 (13), 6121\u20136135 (2016).","journal-title":"J. Med. Chem."},{"issue":"8\u20139","key":"28479_CR55","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.phymed.2014.04.029","volume":"21","author":"YF Sun","year":"2014","unstructured":"Sun, Y. F. & Wink, M. Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania Tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells. Phytomedicine 21 (8\u20139), 1110\u20131119 (2014).","journal-title":"Phytomedicine"},{"issue":"6","key":"28479_CR56","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.cell.2017.01.041","volume":"168","author":"ZL Johnson","year":"2017","unstructured":"Johnson, Z. L. & Chen, J. Structural basis of substrate recognition by the multidrug resistance protein MRP1. Cell 168 (6), 1075\u20131085 (2017). e9.","journal-title":"Cell"},{"key":"28479_CR57","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fphar.2017.00238","volume":"8","author":"O Kadioglu","year":"2017","unstructured":"Kadioglu, O. et al. Mode of action analyses of neferine, a bisbenzylisoquinoline alkaloid of Lotus (Nelumbo nucifera) against multidrug-resistant tumor cells. Front. Pharmacol. 8, 238 (2017).","journal-title":"Front. Pharmacol."},{"issue":"3","key":"28479_CR58","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1021\/jm050800q","volume":"49","author":"L Fang","year":"2006","unstructured":"Fang, L. et al. Discovery of a Daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance. J. Med. Chem. 49 (3), 932\u2013941 (2006).","journal-title":"J. Med. Chem."},{"key":"28479_CR59","doi-asserted-by":"publisher","first-page":"640656","DOI":"10.3389\/fonc.2021.640656","volume":"11","author":"XY Chen","year":"2021","unstructured":"Chen, X. Y. et al. Overexpression of ABCC1 confers drug resistance to betulin. Front. Oncol. 11, 640656 (2021).","journal-title":"Front. Oncol."},{"key":"28479_CR60","doi-asserted-by":"publisher","first-page":"648407","DOI":"10.3389\/fphar.2021.648407","volume":"12","author":"H Xiao","year":"2021","unstructured":"Xiao, H. et al. Clinically-relevant ABC transporter for anti-cancer drug resistance. Front. Pharmacol. 12, 648407 (2021).","journal-title":"Front. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28479-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28479-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28479-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T13:05:23Z","timestamp":1777122323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28479-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28479"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28479-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,23]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have read and adhered to the journal\u2019s ethical standards for manuscript submissions. This article does not contain any studies with human participants or animals performed by any of the authors. We declare that the submitted manuscript does not contain previously published materials and is not considered for publication elsewhere. All the authors have contributed to conception and design, collection, analysis, and interpretation of data, writing or revising the manuscript, or providing guidance on the research\u2019s execution.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}],"article-number":"45162"}}